Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial have?
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial has 278 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial published?
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial has 2020 year in the ScholarIQ index.
What is the open-access status of Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial?
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial has closed oa status in the ScholarIQ index.
What is the DOI of Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial?
The DOI for Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial is on the source record.
What is the PMID of Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial?
The PMID for Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial is on the source record.
What is the OpenAlex record for Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial?
The OpenAlex for Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial is on the source record.